“This breakthrough will allow access to all appropriate treatment options and will eliminate potential guesswork by doctors who are often overwhelmed with the amount of new data and treatment options,” said George Daneker, Jr., MD, Chief Medical Officer at CTCA® at Southeastern Regional Medical Center. “Patients will be able to access and review the data, allowing them to choose safe and efficient treatment options.”
The breakthrough platform will allow patients to review custom treatment regimens that patient specific, access to supporting clinical data, and comparisons between different treatment options, including the market cost.
“Cancer Treatment Centers of America, NantHealth, and Allscripts began the planning phase of the project in 2016,” said Allscripts Chief Executive Officer Paul Black. “A thorough analysis of clinical workflow and strategic design have allowed us to deliver a solution that will assist in the delivery of better treatment care options and optimize the quality of care provided by CTCA.”
The CTCA was founded in 1998. Its first hospital was built in 1988, followed by the construction of four more hospitals from 2005 to 2012. CTCA’s first international information opened in Mexico in 2015.
The CTCA is accredited by multiple organizations. The CTCA has earned Five Star quality ratings by the U.S. Centers for Medicare & Medicaid Services, and the National Accreditation Program for Breast Centers has awarded three-year full accreditation to four of the five CTCA hospitals for their breast cancer treatment programs.